News
- Author:
- Mark S. Lesney
Publish date: March 26, 2020
Patients over the age of 80 years received similar benefits as patients 70-79 years old from MM treatment....
News
- Author:
- Mark S. Lesney
Publish date: March 25, 2020
A particular microRNA was found to be associated with prevascular invasion.
News
- Author:
- Mark S. Lesney
Publish date: March 23, 2020
Patients in gene therapy trials and those with factor inhibitors are of particular concern.
News
- Author:
- Mark S. Lesney
Publish date: March 19, 2020
Screening patients, personal protection, procedure postponement, and special precautions with infected patients are discussed.
News
- Author:
- Mark S. Lesney
Publish date: March 17, 2020
FL-directed therapy was associated with an overall survival benefit, which persisted.
News
- Author:
- Mark S. Lesney
Publish date: March 16, 2020
The American Society for Transplantation and Cellular Therapy document focuses on patient-treatment specifics and donor issues.
News
- Author:
- Mark S. Lesney
Publish date: March 13, 2020
Screening for vitamin D deficiency may show benefits, authors suggest.
News
- Author:
- Mark S. Lesney
Publish date: March 12, 2020
The correlation was seen especially in infant boys and those with minimally differentiated leukemia.
News
- Author:
- Mark S. Lesney
Publish date: March 12, 2020
Despite new treatment strategies there was no decreased fracture risk for multiple myeloma patients over time.
News
- Author:
- Mark S. Lesney
Publish date: March 11, 2020
Patients with less than 20% marrow CLL involvement before transplant had an improved 4 year survival.
News
- Author:
- Mark S. Lesney
Publish date: March 6, 2020
The use of fludarabine (Flu) may affect the occurrence of secondary graft failure for aplastic anemia with both r...
News
- Author:
- Mark S. Lesney
Publish date: March 5, 2020
A clinically proven effective protease inhibitor blocks SARS-CoV-2 virus entrance sites.
News
- Author:
- Mark S. Lesney
Publish date: March 5, 2020
Injections of long-acting suspensions of cabotegravir and rilpivirine show promise for the control of HIV.
News
- Author:
- Mark S. Lesney
Publish date: February 26, 2020
CD229 CAR T cells are highly active in vitro and in vivo against multiple myeloma plasma cells, memory B cells, and MM-propagating cells.
Opinion
- Author:
- Mark S. Lesney
Publish date: February 25, 2020
From “Wuhan virus” to “novel coronavirus-2019” to “COVID-19 virus” to “SARS-CoV-2,” the process of naming is complex and even risky to public healt...
